CurrowDCWheelerJLGlarePA, et al. A framework for generalizability in palliative care. J Pain Symptom Manage2009; 37(3): 373–386.
2.
JordhøyMSSaltvedtIFayersP, et al. Which cancer patients die in nursing homes? Quality of life, medical and sociodemographic characteristics. Palliat Med2003; 17(5): 433–444.
3.
SchloemerTSchröder-BäckP.Criteria for evaluating transferability of health interventions: a systematic review and thematic synthesis. Implement Sci2018; 13(1): 88.
4.
CurrowDCAllinghamSBirdS, et al. Referral patterns and proximity to palliative care inpatient services by level of socio-economic disadvantage. A national study using spatial analysis. BMC Health Serv Res2012; 12(1): 424.
5.
LuckettTPhillipsJAgarM, et al. Elements of effective palliative care models: a rapid review. BMC Health Serv Res2014; 14(1): 136.
6.
BauseweinCDavesonBACurrowDC, et al. EAPC White Paper on outcome measurement in palliative care: improving practice, attaining outcomes and delivering quality services–Recommendations from the European Association for Palliative Care (EAPC) Task Force on Outcome Measurement. Palliat Med2016; 30(1): 6–22.
7.
RowettDCurrowD.Pharmacovigilance in palliative care. Aust Prescr2014; 37(6): 204–209.
8.
CurrowDCStevensonJPAbernethyAP, et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc2007; 55(4): 590–595.
9.
MorganNARowettDCurrowDC.Analysis of drug interactions at the end of life. BMJ Support Palliat Care2015; 5(3): 281–286.
10.
CrawfordGBAgarMMQuinnSJ, et al. Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium. J Palliat Med2013; 16(11): 1335–1341.
11.
CurrowDCRowettDDoogueM, et al. An international initiative to create a collaborative for pharmacovigilance in hospice and palliative care clinical practice. J Palliat Med2012; 15(3): 282–286.
